StreetInsider.com News Articles

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,000 at Deutsche Bank

Fri, 09 Oct 2026 06:05:38 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,000.00 (from DKK2,750.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,000 at Deutsche Bank

Fri, 09 Oct 2026 06:05:38 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,000.00 (from DKK2,750.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,000 at Deutsche Bank

Fri, 09 Oct 2026 06:05:38 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,000.00 (from DKK2,750.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,000 at Deutsche Bank

Fri, 09 Oct 2026 06:05:38 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,000.00 (from DKK2,750.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,100 at Barclays

Fri, 09 Oct 2026 01:37:14 -0400

Barclays analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,100.00 (from DKK2,900.00) while maintaining a Overweight rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,100 at Barclays

Fri, 09 Oct 2026 01:37:14 -0400

Barclays analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,100.00 (from DKK2,900.00) while maintaining a Overweight rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,100 at Barclays

Fri, 09 Oct 2026 01:37:14 -0400

Barclays analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,100.00 (from DKK2,900.00) while maintaining a Overweight rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK3,100 at Barclays

Fri, 09 Oct 2026 01:37:14 -0400

Barclays analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK3,100.00 (from DKK2,900.00) while maintaining a Overweight rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK2,750 at Deutsche Bank

Wed, 07 Oct 2026 04:25:31 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,500.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK2,750 at Deutsche Bank

Wed, 07 Oct 2026 04:25:31 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,500.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK2,750 at Deutsche Bank

Wed, 07 Oct 2026 04:25:31 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,500.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK2,750 at Deutsche Bank

Wed, 07 Oct 2026 04:25:31 -0400

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,500.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Lowered to DKK2,750 at UBS

Tue, 02 Apr 2024 23:39:52 -0400

UBS analyst Xian Deng lowered the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,800.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Lowered to DKK2,750 at UBS

Tue, 02 Apr 2024 23:39:52 -0400

UBS analyst Xian Deng lowered the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,800.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Lowered to DKK2,750 at UBS

Tue, 02 Apr 2024 23:39:52 -0400

UBS analyst Xian Deng lowered the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,800.00) while maintaining a Buy rating.

Genmab A/S (GEN:DC) (GMXAY) PT Lowered to DKK2,750 at UBS

Tue, 02 Apr 2024 23:39:52 -0400

UBS analyst Xian Deng lowered the price target on Genmab A/S (GEN:DC) (OTC: GMXAY) to DKK2,750.00 (from DKK2,800.00) while maintaining a Buy rating.

Deutsche Bank Upgrades Genmab A/S (GEN:DC) (GMXAY) to Buy

Fri, 10 Nov 2023 01:52:32 -0400

Deutsche Bank analyst Emmanuel Papadakis upgraded Genmab A/S (GEN:DC) (OTC: GMXAY) from Hold to Buy with a price target of DKK2,750.00.

Deutsche Bank Upgrades Genmab A/S (GEN:DC) (GMXAY) to Buy

Fri, 10 Nov 2023 01:52:32 -0400

Deutsche Bank analyst Emmanuel Papadakis upgraded Genmab A/S (GEN:DC) (OTC: GMXAY) from Hold to Buy with a price target of DKK2,750.00.

Deutsche Bank Upgrades Genmab A/S (GEN:DC) (GMXAY) to Buy

Fri, 10 Nov 2023 01:52:32 -0400

Deutsche Bank analyst Emmanuel Papadakis upgraded Genmab A/S (GEN:DC) (OTC: GMXAY) from Hold to Buy with a price target of DKK2,750.00.

Deutsche Bank Upgrades Genmab A/S (GEN:DC) (GMXAY) to Buy

Fri, 10 Nov 2023 01:52:32 -0400

Deutsche Bank analyst Emmanuel Papadakis upgraded Genmab A/S (GEN:DC) (OTC: GMXAY) from Hold to Buy with a price target of DKK2,750.00.

Genmab A/S (GEN:DC) (GMXAY) PT Raised to DKK2,800 at Citi

Tue, 01 Aug 2023 05:42:08 -0400